Main Navigation
 
Search
Advanced Search>>
Free Newsletter
Subscribe
Unsubscribe
 
 
  
Health Headlines

Get the latest news in prevention and health matters. This feature includes daily postings and recent archives to keep you up to date on health reports and wires around the world.
Weekly Wellness
Get informed with weekly wellness facts in a diversity of health topics from prevention to fitness and nutrition.
Tips
Great tips on what you need to know about keeping healthy and active all year round.

 

Vitamins to Save Eyes
Could Save Money, Too
Excerpt By Martha Kerr, Reuter's Health

ORLANDO (Reuters Health) - Giving high-dose vitamin therapy to people suffering from the leading cause of age-related blindness could save money, as well as their sight, a Canadian researcher told attendees of the annual meeting of the American Academy of Ophthalmology here.

The condition, age-related macular degeneration (AMD), occurs when light-sensitive cells in the macula, the tissue at the center of the retina, break down. This can make it difficult to read, drive or perform other activities that require sharp vision.

Ninety percent of AMD patients have so-called "dry" AMD. While there is currently no cure for dry AMD, a study published by the National Eye Institute last year showed that taking a combination of zinc, vitamins C and E and beta-carotene, may slow disease progression.

Dr. Sanjay Sharma of Queens University in Kingston, Ontario, told Reuters Health that by his calculations, the vitamin therapy could save the US healthcare system $1.56 billion over the next 10 years if taken by patients with moderately advanced AMD.

Sharma and colleagues used a number of decision analyzes and cost-utility models to determine the cost of high-dose vitamin therapy for this patient population, as well as information from the Age-Related Eye Disease study.

"We tried to look at it from the point of view of the insurers," Sharma said, in order to determine how expensive the treatment approach would be and whether or not insurers could be encouraged to reimburse patients for the cost.

High-dose vitamin therapy for AMD "was thought to be an expensive approach." But the investigators found that it saves money "because of the reduced demand for very expensive services at the other end (of the disease process)."

By slowing disease progression, "you dramatically improve quality of life over a 5-year period," Sharma added.

"It makes sense for insurers to pick up the tab," Sharma asserted. Insurers "could expect a 5-year saving of $130 per patient by recommending high-dose vitamin therapy for their beneficiaries with advanced dry AMD," the Canadian team reported.

Reference Source 89

For more information on how to prevent other diseases, use
PreventDisease.com's "Quick Prevention Resources".

Select a Channel